Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

55 results about "Als gene" patented technology

Genetic mutations associated with ALS. A large number of genetic mutations have been associated with ALS. These mutations do not definitely cause ALS but can increase a person’s risk of developing the disease. The C9ORF72 gene is the most frequently mutated gene in ALS patients.

Applications of ALS (acetolactate synthase) mutant type protein based on gene editing technology and ALS mutant type protein gene in plant breeding

The invention discloses a rice ALS (acetolactate synthase) mutant type protein, a mutant type gene and applications of the rice ALS mutant type protein and the mutant type gene. The amino acid sequence of the ALS mutant type protein has following mutation: the 628-poisiton amino acid corresponding to the amino acid sequence of rice ALS has the mutation. The invention further discloses a breeding method of creating herbicide-resistant rice by gene editing. The CRISPR / Cas9 gene editing technology is used for editing the ALS gene for the first time, a T-DNA-knockout new material with the stably inherited herbicide resistant characteristic can be obtained in the T2 generation through offspring screening, and basic agronomic traits of the new material have no obvious change. Compared with breeding based on chemical mutagenesis, hybrid transform breeding and the like, the orderly improved molecular breeding technology based on gene editing has the advantages of being rapid, accurate, efficient and the like, and by means of combination with gene function marked genotype selection, breeding efficiency can be greatly increased and breeding progress is substantially accelerated.
Owner:JIANGSU ACAD OF AGRI SCI

Escherichia coli genetically engineered bacterium and application of escherichia coli genetically engineered bacterium to synchronous production of L-tryptophan and L-valine through fermentation

The invention provides an escherichia coli genetically engineered bacterium for the synchronous high yield of L-tryptophan and L-valine, and application thereof. The genetically engineered bacterium is obtained through the steps that on a genome of escherichia coli, trpE (S40F) mutation is introduced while a promoter of tryptophan operon is replaced with a Ptrc promoter; an aroG (S180F) gene controlled by the Ptrc promoter is integrated to a tyrR locus; a serA (H344A, N364A) gene controlled by a Plac promoter is integrated to a yjiV pseudo gene locus; a glnA gene controlled by the Plac promoter is integrated to a ycjV pseudo gene locus; and then a bacillus subtilis alsS gene controlled by the Ptrc promoter is integrated to a yghx pseudo gene locus. Shaking flask fermentation is conducted through a strain to be able to accumulate the L-tryptophan within 22-28 h to 10-14 g / L, meanwhile the accumulation amount of valine reaches 5-7 g / L, and the total acid-producing ability is improved by50% or so compared with that of a tryptophan producing strain; and meanwhile, strain OD600 is different slightly, growth problems are avoided, but the acid-producing ability per strain is obviously improved by 120%, and effective utilization of carbon sources and cells is improved greatly.
Owner:TIANJIN UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products